Trump's CDMO Investment Surge and Manufacturing Onshoring (Episode 3) скачать в хорошем качестве

Trump's CDMO Investment Surge and Manufacturing Onshoring (Episode 3)

In this episode of the DES Pharma Podcast, we break down the massive shifts hitting the pharmaceutical industry in 2025 and 2026. From the White House's aggressive "Most Favored Nations" executive order to Johnson & Johnson’s massive $2 billion investment in North Carolina, the landscape of drug manufacturing is changing fast. Join us as we discuss the return of US manufacturing, the risks of tariffs, and how companies must adapt their supply chain strategies to survive the new regulatory era. https://despharmaconsulting.com/ #PharmaNews #SupplyChain #Pharmaceuticals #JNJ #Biotech #Manufacturing #FDA #DrugPricing #DEESPharma #BusinessStrategy Chapters: 0:00 Intro 0:36 Pricing Executive Order 1:50 J&J’s $2B Move 4:48 The CDMO Surge 6:29 Small Pharma Risks 8:50 US Manufacturing Boom 10:29 Post-Pandemic Inventory 12:44 Pricing Pressure Strategy 13:50 Surviving New Tariffs 15:35 Strategic Summary Disclaimer: This content is for informational purposes only and does not constitute regulatory or legal advice. Always engage directly with the FDA and your advisors.